Results 11 to 20 of about 13,667 (181)

Pathogenesis of Lassa Fever

open access: yesViruses, 2012
Lassa virus, an Old World arenavirus (family Arenaviridae), is the etiological agent of Lassa fever, a severe human disease that is reported in more than 100,000 patients annually in the endemic regions of West Africa with mortality rates for ...
David H. Walker, Nadezhda E. Yun
doaj   +4 more sources

Development of a new vaccine for the prevention of Lassa fever.

open access: yesPLoS Medicine, 2005
BACKGROUND: Recent importation of Lassa fever into Germany, the Netherlands, the United Kingdom, and the United States by travelers on commercial airlines from Africa underscores the public health challenge of emerging viruses.
Thomas W Geisbert   +15 more
doaj   +3 more sources

Detection of Lassa Virus, Mali [PDF]

open access: yesEmerging Infectious Diseases, 2010
To determine whether Lassa virus was circulating in southern Mali, we tested samples from small mammals from 3 villages, including Soromba, where in 2009 a British citizen probably contracted a lethal Lassa virus infection.
David Safronetz   +10 more
doaj   +2 more sources

Comparative studies on Mopeia viruses and other Arenaviridae, particularly Lassa virus [PDF]

open access: yes, 1983
This thesis was submitted for the degree of Doctor of Philosophy and awarded by Brunel University.Serologically related arenaviruses have been isolated from West Africa, Mozambique, Zimbabwe and the Central African Republic.
Lloyd, Graham
core   +8 more sources

Space-Time Trends in Lassa Fever in Sierra Leone by ELISA Serostatus, 2012–2019

open access: yesMicroorganisms, 2021
Lassa fever (LF) is a viral hemorrhagic disease found in Sub-Saharan Africa and is responsible for up to 300,000 cases and 5000 deaths annually. LF is highly endemic in Sierra Leone, particularly in its Eastern Province.
Jeffrey G. Shaffer   +19 more
doaj   +1 more source

Diversity in responses to oncolytic Lassa-vesicular stomatitis virus in patient-derived glioblastoma cells

open access: yesMolecular Therapy: Oncolytics, 2021
The difficulty of glioblastoma treatment makes it a good candidate for novel therapies, such as oncolytic viruses. Vesicular stomatitis virus expressing Lassa virus glycoprotein (Lassa-VSV) showed significant promise in animal models using established ...
Teddy E. Kim   +8 more
doaj   +1 more source

Expansion of CD8+ T cell population in Lassa virus survivors with low T cell precursor frequency reveals durable immune response in most survivors.

open access: yesPLoS Neglected Tropical Diseases, 2022
IntroductionLassa virus is a priority pathogen for vaccine research and development, however the duration of cellular immunity and protection in Lassa fever (LF) survivors remains unclear.MethodsWe investigated Lassa virus specific CD8+ T cell responses ...
Stephanie M LaVergne   +10 more
doaj   +1 more source

Analysis of Determinants in Filovirus Glycoproteins Required for Tetherin Antagonism

open access: yesViruses, 2014
The host cell protein tetherin can restrict the release of enveloped viruses from infected cells. The HIV-1 protein Vpu counteracts tetherin by removing it from the site of viral budding, the plasma membrane, and this process depends on specific ...
Kerstin Gnirß   +7 more
doaj   +1 more source

Challenges and Opportunities in Lassa fever Control Efforts in Nigeria

open access: yesThe Proceedings of the Nigerian Academy of Science, 2022
Lassa fever is a viral zoonotic tropical disease endemic in parts of West Africa. It causes substantial mortality, morbidity and economic burdens on affected populations.
Anise N. Happi   +3 more
doaj   +1 more source

A GIS-BASED APPROACH TO RISK MAPPING OF LASSA FEVER OUTBREAK IN AKURE SOUTH LOCAL GOVERNMENT AREA, NIGERIA [PDF]

open access: yesThe International Archives of the Photogrammetry, Remote Sensing and Spatial Information Sciences, 2022
Lassa fever is an acute viral illness, which is endemic in some counties in West Africa, including Guinea, Liberia, Sierra Leone and parts of Nigeria.
O. J. Ifejube   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy